Just Other Articles

A strategic plan is crafted to secure the desired results through specific business goals. Thi

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

s may be a simple process for the small business owner to a very complicated process for Fortun

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

100 companies.

Monitoring the progress of the business goals is necessary to ensure effective

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

execution. This monitoring should be conducted through regular meetings that are focused on the

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

plan and only the plan. Other business and performance issues should be directed to separate m

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

eetings.

When conducting these meetings, it is imperative that the purpose is monitoring the p

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ogress and results of the goals within the strategic plan. Many times in business, people conf

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

se motion with progress and activity with results.

These regularly, either weekly or bi-monthl

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

, conducted meetings usually helps everyone to keep a focus on the progress and results of the

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

business goals. Also, if unforeseen obstacles happen, then course corrections can be made to t

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e plan so that the impact will not be as severe.

In recent years, a new component has been add

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

d to most strategic plans – the business dashboard. By identifying key performance indicators

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

hat are monitored either daily or weekly, the company has the ability to make even quicker cour

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

se corrections. These key performance indicators are grouped together in what is called the bu

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

iness dashboard. Much like the dashboard of your car, the purpose is to quickly see what is go

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ng right such as enough fuel and identify any potential problems such as Check Engine Light. T

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

e business dashboard could be the agenda for each of these meetings.

Yes, you can have an exec

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

utable strategic plan provided you remember to regularly monitor the progress and results of yo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

r business goals. By not doing so, is an invitation to disaster.

P.S. Read the elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

"href="http://EzineArticles.com/?id=587277">7 Top Tips on How to Execute Your Strategic Plan

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

A genuine and friendly greeting and the truest form of gratefulness for the patronage-

The realm of industrial general purpose absorbents is wide. Not only are you considering a powder to absorb spilled liquid, but there are also pads, pans, rolls, cloths and more. Within this realm there are also a variety of absorbents that can be used specifically for oil, HAZMAT materials and general purpose absorbents.

If you run a non-profit business then perhaps you should try direct marketing and direct-mail to get volunteers and increase donations to your non-profit. Direct-mail and direct marketing does not just work for businesses, as it is a way to catch people in their homes who read direct-mail and direct marketing packages.

Tags

Links

Just Other Articles - Effective Execution of Your Strategic Plan Requires Monitoring of All Goals and Your Dashboard

Related Articles: